Gad Shani

Thulium Therapy is developing a new radioactive source for Brachytherapy, a cancer treatment modality were a radiation source is inserted into the tumor. The isotope, Thulium 170 (Tm170), is a radioactive variant of the stable metal Tm169. Although the concept of Brachytherapy is not new, much room remains for improvement in order to maximize the probability of completely eliminating a localized tumor while minimizing the radiation damage to the surrounding healthy tissue.